NASDAQ · NA
Nano Labs financials
$2.17−0.91%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $3.9M | $5.6M | $11.1M | $142.5M |
| Gross profit | -$5.7M | $1.6M | -$14.6M | $33.4M |
| Gross margin | −147.3% | 28.6% | −132.1% | 23.4% |
| Operating income | $10.2M | -$15.7M | -$36.8M | $3.0M |
| Net income | $19.4M | -$15.5M | -$35.7M | $4.5M |
| Net margin | 501.6% | −278.8% | −322.7% | 3.2% |
| Diluted EPS | $0.97 | $-1.93 | $-6.07 | $0.85 |
| EBITDA | $11.8M | -$14.3M | -$36.2M | $3.6M |
| Operating cash flow | -$15.5M | -$19.1M | -$18.9M | -$39.9M |
| Free cash flow | -$15.5M | -$24.1M | -$33.8M | -$42.4M |
| Diluted shares | 19.9M | 8.0M | 5.9M | 5.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $1.2M | $4.4M | $6.8M | $12.6M |
| Short-term investments | $3.7M | $0.00 | $0.00 | — |
| Total debt | $31.6M | $26.6M | $20.3M | $2.4M |
| Total assets | $160.0M | $84.4M | $49.5M | $52.7M |
| Total liabilities | $54.1M | $52.5M | $51.8M | $29.1M |
| Shareholders' equity | $105.9M | $31.9M | -$2.3M | $23.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology